mitomycin has been researched along with piperine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Cui, LD; Han, SZ; Liu, HX; Xu, Y; Yang, LQ | 1 |
2 other study(ies) available for mitomycin and piperine
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-κB.
Topics: Alkaloids; Animals; Apoptosis; Benzodioxoles; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; Male; Mice; Mice, Nude; Mitomycin; NF-kappa B; Piperidines; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor; Uterine Cervical Neoplasms | 2017 |